The National Institute for Health and Clinical Excellence (NICE) issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on radiotherapy for age-related macular degeneration.

This guidance was considered for reassessment in January 2011.  It was concluded that NICE will not be updating this guidance as investigations have suggested that radiotherapy for age-related macular degeneration has been superseded by other techniques.


Age-related macular degeneration is the commonest cause of irreversible blindness in developed countries. Radiotherapy can be used to destroy new vessels in the wet form of maacular degeneration. It is usually given as a day treatment. The beam of radiotherapy is angled to avoid damage to the optic nerve and structures in the other eye.

Coding recommendations


SNOMED CT preferred term (concept ID)

Destruction of lesion of retina by radiation therapy (231764006)

 C82.3 External beam radiotherapy to lesion of retina NEC

Includes: Radiotherapy to lesion of retina NEC

X65.4 Delivery of a fraction of external beam radiotherapy NEC

Y91.- External beam radiotherapy

In addition the ICD-10 code H35.3 Degeneration of macula and posterior pole would be recorded.

Diagnosis or health condition

SNOMED CT preferred term (concept ID)

Age related macular degeneration (267718000)